Shree Ganesh Bio-Tech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
For the six months, sales was INR 334.76 million compared to INR 1.14 million a year ago. Revenue was INR 335.24 million compared to INR 1.14 million a year ago. Net income was INR 15.06 million compared to net loss of INR 0.795 million a year ago. Basic earnings per share from continuing operations was INR 0.038 compared to basic loss per share from continuing operations of INR 0.002 a year ago. Diluted earnings per share from continuing operations was INR 0.038 compared to diluted loss per share from continuing operations of INR 0.002 a year ago.